biotech
Novartis Receives European Commission Approval To Acquire Chiron
Filed in archive Corporate and Industrial News by ruth on February 7, 2006
BlogPicture

Novartis announced yesterday that the European Union antitrust regulators approved of its takeover of Chiron Corp. When I first blogged about the takeover here in this weblog, I thought it was a done deal. I didn't realize there were issues to be settled with the European Commission. Oh well, seems all that's cleared up now.
A monthlong European Commission investigation found "little or no overlaps exist between Novartis' and Chiron's product ranges,'' the EU head office said in a statement, adding that there was little potential competition overlaps between the two companies.

Novartis is paying $5.1 billion for the 58 percent of the Emeryville, Calif.-based company it doesn't already control.


Read more from Novartis or from SiliconValley.com.

Permalink: Novartis Receives European Commission Approval To Acquire Chiron
Tags: novartis  chiron  biotech  european  commission  european+commission  novartis+receives  acquire+chiron 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/15116
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Novartis Receives European Commission Approval To Acquire Chiron:

  • Currently 7.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.00 out of 2 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!